Intelligent Relations
Preston by Intelligent Relations
Zachary Brennan
Gray shield icon
Is this you?
Claim your profile.

Zachary Brennan

Senior Editor

AS SEEN ON
Endpoints News

Preston's Summary

Zachary Brennan is a senior editor at Endpoints, covering the US regulatory agency and global counterparts. His reporting focuses on pharmaceutical regulation, health news, and public health issues, with a particular emphasis on the biopharma industry and oncology topics. Zachary has been featured in the Cureus Journal of Medical Science and Global Advertising News.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Informative: 62 %
Reviews: 16 %
Opinion: 8 %
Data Driven: 6 %
Promotional: 3 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Pharmaceutical Regulation
  • Drugs & Medication
  • Health News
  • Oncology
  • Pancreatic Cancer Research
  • Pharmaceutical Manufacturing
  • Lawsuits
  • Public Health

Pitching Insights

Zachary Brennan's coverage overwhelmingly focuses on healthcare and pharmaceuticals, particularly around government announcements and legal policy regulations. He seems most interested in covering stories related to the FDA, drug approval processes, drug pricing, pharmaceutical companies, and clinical trials.

Given this focus, Zachary would likely be highly receptive to pitches from experts within the healthcare industry who can provide insights into regulatory changes impacting drug approvals or pricing. Additionally, professionals with expertise in clinical trials oversight or experience navigating FDA processes may find success reaching out to him for commentary.

As his geographic focus is not specified but given the nature of his reporting which heavily involves U.S. government agencies such as the FDA and specific U.S.-related policies like drug price regulation laws; it is fair to assume he has a U.S.-centric perspective.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Max Bayer

Max Bayer

Pharma Reporter
*****m@*********om
Publications
Endpoints News, NewsBreak
Most recent topics
Not enough data
Lizzy Lawrence

Lizzy Lawrence

Fda Reporter
Publications
STAT News, The Wall Street Journal
Most recent topics
Not enough data
Nicole Defeudis

Nicole Defeudis

Editor
*****e@********om
Publications
Endpoints News, NewsBreak
Most recent topics
Not enough data
Max Gelman

Max Gelman

Senior Editor
**x@**************com
Publications
Endpoints News, orbimed.com
Most recent topics
Not enough data
Anna Brown

Anna Brown

News Reporter
*****n@**************com
Publications
Endpoints News, Business NH Magazine, The Tab
Most recent topics
Not enough data
Mari Serebrov

Mari Serebrov

Regulatory Editor
**********rov@**********com
Publications
BioWorld
Most recent topics
Not enough data

Articles

© 2026 Intelligent Relations